How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

There Is Something We Have to Do Right Now About A.I. Artificial intelligence labs are on the verge of handing over the training of A.I. to A.I. We should stop them. There’s a chasm right now between ...

Contrary to what you might believe, there is no reward for being the overworked man or woman of the year. Furthermore, you may not be the best person for the job, and it's perfectly fine to redirect ...

Make strategic thinking part of your daily routine. "HBR Daily Strategist" provides 365 days' worth of insights and inspiration to help you build a regular... Book Test more. Assume less. How a ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...